Christopher Y. Chai, Chief Financial Officer at MAP Pharmaceuticals, Inc. (MAPP), sold 10,000 shares at $10.26 ($103K) on 2009-10-01, disclosed to the SEC on 2009-10-05.
Scheduled sale ($103k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PRNB | SELL | 2020-02-20 | $818K | — | Filing → |
| MAPP | SELL | 2011-09-22 | $492K | — | Filing → |
| MAPP | SELL | 2010-09-22 | $225K | — | Filing → |